🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will investigate the influence of MK0859 on ambulatory blood pre...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00565006
Treatments Being Tested
This study will evaluate the safety and effect of anacetrapib on low-densit...
Status
Terminated
Location
Multiple Locations
Start Date
2013-06
Trial ID
NCT01841684
Treatments Being Tested
The objective of this study is to evaluate the efficacy and tolerability of...
Status
Completed
Location
Multiple Locations
Start Date
2012-02-03
Trial ID
NCT01524289
Treatments Being Tested
This study will evaluate the effects of 2 different dose levels of anacetra...
Status
Completed
Location
Multiple Locations
Start Date
2012-11-06
Trial ID
NCT01717300
This study will evaluate the effects of anacetrapib (MK-0859) on low-densit...
Status
Completed
Location
Multiple Locations
Start Date
2013-05
Trial ID
NCT01824238
Treatments Being Tested
This study will investigate the effect of MK0859 on lipoprotein metabolism ...
Status
Completed
Location
Multiple Locations
Start Date
2009-11
Trial ID
NCT00990808
To assess the cholesterol changing effects of MK0859 in patients with prima...
Status
Terminated
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00325455
Treatments Being Tested
This is a study to assess the safety, efficacy, and tolerability of MK0859 ...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00565292
Treatments Being Tested
This study will investigate the effect of MK0859 when administered alone an...
Status
Completed
Location
Multiple Locations
Start Date
2009-09
Trial ID
NCT00977288
Treatments Being Tested
The Randomized EValuation of the Effects of Anacetrapib Through Lipid-modif...
Status
Active Not Recruiting
Location
CTSU, University of Oxford
Start Date
2011-06
Trial ID
NCT01252953
Treatments Being Tested